Medical ozone therapy can be a promising new treatment for life-threatening sepsis-induced acute lung injury (ALI), researchers have said. Sepsis is a severe and often fatal complication of infection and is a leading cause of both acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
This innovative method could significantly improve survival rates and lung function in preclinical models, offering hope for patients with limited treatment options, according to the study from researchers from Nanjing Medical University in China.
Neutrophil extracellular traps (NETs) play a central role in the progression of sepsis, as they are involved in trapping pathogens but can also trigger excessive inflammation, exacerbating lung injury.
The complexity of sepsis-induced ALI, driven by the interplay among inflammation, immune dysregulation, and coagulation, calls for innovative therapeutic strategies to better manage this critical condition.
The study, published in the Journal of Biomedical Research, detailed how medical ozone therapy effectively clear NETs, significantly improving survival rates and lung function in mice suffering from sepsis-induced ALI.
“Our research demonstrates that medical ozone therapy could dramatically improve the management of sepsis-induced ALI. This represents a promising new approach to critical care that could lead to better outcomes for patients suffering from sepsis,” said Dr. Wen-Tao Liu, the principal investigator of the study.
The implications of this study are far-reaching. If subsequent research confirms these results in human trials, medical ozone therapy could become a viable and effective treatment for sepsis-induced lung injury, a condition currently with few treatment options.
Sepsis-induced ALI Symptoms include difficulty breathing, hypoxemia, cough, fever, and accelerated heartbeats. Severe patients may experience shock and multiple organ dysfunction
According to experts not related with this study, conventional treatments come with several limitations. Firstly, the overuse of antibiotics may contribute to the emergence of bacterial resistance. Second, fluid resuscitation can lead to fluid overload and pulmonary edema. Blood product transfusion carries the risk of transfusion-related complications. Lastly, the administration of vasoactive drugs can result in significant blood pressure fluctuations and elevate the risk of cardiovascular complications.
